PL EN


Preferencje help
Widoczny [Schowaj] Abstrakt
Liczba wyników
2014 | 70 | 01 |

Tytuł artykułu

Szczepionki przeciw kolibakteriozie prosiąt, zwłaszcza okresu poodsadzeniowego

Warianty tytułu

EN
Vaccines against porcine colibacillosis, particularly after weaning

Języki publikacji

PL

Abstrakty

EN
In the introduction to this review paper, the mechanisms of pathogenicity of Eschercihia (E.) coli in animals, including particularly pigs, are characterized. The paper provides definitions of enterotoxigenic pathotype (ETEC), the Shiga-toxin-producing pathotype (STEC), the enteropathogenic pathotype (EPEC), and the extraintestinal pathotype (ExPEC), as well as presents the major types (virotypes) of E. coli that cause neonatal diarrhea in piglets and post-weaning diarrhea in pigs. Neonatal infections are prevented by the vaccination of the pregnant sow, which provides the suckling piglets with passive colostral and lactogenic immunity. The main purpose of this paper was therefore to discuss oral subunit vaccines and live oral vaccines against post- -weaning colibacillosis in pigs. The paper cites literature indicating that subunit vaccines containing purified fimbriae, particularly F4, which are important pathogenicity factors in the colonization of the pig’s intestine, given orally to weaned pigs, can protect them against oral challenge with virulent F4+ETEC. The use of alfalfa plants as a delivery vehicle for F4 is suggested. Positive results obtained for vaccines containing F4 have not been repeated in the case of vaccines with F18. Nevertheless, the above-mentioned results for F4 open new possibilities for the development of combined subunit vaccines against the F4+ and F18+ strains of E. coli, which are the major etiological agents of post-weaning diarrhea in pigs. Further in the paper, live oral ETEC vaccines for the prevention of post-weaning colibacillosis in pigs are characterized. They contain fimbrial live attenuated strains or wild strains, which are a priori non pathogenic, as they do not produce enterotoxins. After oral administration, these bacteria adhere to the fimbrial receptors of intestinal epithelial cells, initiating the immune response of the vaccinated pigs against fimbriae and preventing the colonization of the small intestine. The priming of the immune system with levamisole via intramuscular injection before oral vaccination, improves significantly the post-vaccinal immunity. Based on the this technology, a live vaccine against F4+ETEC post-weaning diarrhea, called Coliprotec, was commercialized by Prevtec microbia in Canada in 2008 and also introduced in Brazil in 2011. The introduction of this vaccine in Europe is planned in 2014. Since post-weaning diarrhea caused by F4+ETEC occurs shortly after the weaning of pigs, the vaccination is recommended shortly before weaning. In order to enhance the efficacy of subunit and live vaccines administered orally to pigs, it is recommended to encapsulate them for protection of their immunogenic properties during transport through the gastrointestinal tract. Parenteral vaccination against post-weaning porcine colibacillosis stimulates above all the systemic rather than the mucosal immune system. Its value in protecting the pigs against post-weaning colibacillosis is therefore small or none. Considering the serious losses caused by post-weaning colibacillosis in swine production, further research is needed to improve the efficacy of vaccines against this disease. An effective vaccine could also make it possible to reduce the use of antimicrobials, as called for by the WHO and the OIE.

Wydawca

-

Rocznik

Tom

70

Numer

01

Opis fizyczny

s.3-6,bibliogr.

Twórcy

  • Zakład Chorób Świń, Państwowy Instytut Weterynaryjny - Państwowy Instytut Badawczy, Al. Partyzantów 57, 24-100 Puławy
autor
  • Zakład Chorób Świń, Państwowy Instytut Weterynaryjny - Państwowy Instytut Badawczy, Al. Partyzantów 57, 24-100 Puławy

Bibliografia

  • 1. Bertschinger H. U., Nief V., Tschäpe H.: Active oral immunization of suckling piglets to prevent colonization after weaning by enterotoxigenic Escherichia coli with fimbriae F18. Vet. Microbiol. 2000, 71, 255-267.
  • 2. Blanco M., Blanco J. E., Gonzales E. A., Mora A., Jansen W., Gomes T. A. T., Zerbini L. F., Yano T., Pestana de Castro A. F., Blanco J.: Genes coding for enterotoxins and verotoxins in porcine Escherichia coli strains belonging to different O:K:H: serotypes: relationship with toxic phenotypes. J. Clin. Microbiol. 1997, 35, 2958-2963.
  • 3. Bozić F., Bilić V., Valpotić I.: Levamisole mucosal adjuvant activity for a live attenuated Escherichia coli oral vaccine in weaned pigs. J. Vet. Pharmacol. Ther. 2003, 26, 225-231.
  • 4. Bozić F., Lacković G., Stokes C. R., Valpotić I.: Recruitment of intestinal CD45RA+ and CD45RC+ cells induced by a candidate oral vaccine against porcine post-weaning colibacillosis. Vet. Immunol. Immunopathol. 2002, 86, 137-146.
  • 5. Broeck W. Van den, Cox E., Goddeeris B. M.: Induction of immune responses in pigs following oral administration of purified F4 fimbriae. Vaccine 1999, 17, 2020-2029.
  • 6. Broeck W. Van den, Cox E., Goddeeris B. M.: Receptor-dependent immune responses in pigs after oral immunization with F4 fimbriae. Infect. Immun. 1999, 67, 520-526.
  • 7. Casey T. A., Nagy B., Moon H. W.: Pathogenicity of porcine enterotoxigenic Escherichia coli that do not express K88, K99, F41, or 987P adhesins. Am. J. Vet. Res. 1992, 53, 1488-1492.
  • 8. Fairbrother J. M., Gyles C. L.: Colibacillosis, [w:] Zimmerman J. J., Karriker L. A., Ramirez A., Schwartz K. J., Stevenson G. W.: Diseases of Swine. Wiley-Blackwell, Ames, Iowa, USA 2012, 10th ed., 723-749.
  • 9. Fairbrother J. M., Nadeau E., Gyles C. L.: Escherichia coli in postweaning diarrhea in pigs: an update on bacterial types, pathogenesis, and prevention strategies. Anim. Health Res. Rev. 2005, 6, 17-39.
  • 10. Girardeau J. P.: A new in vitro technique for attachment to intestinal villi using enteropathogenic Escherichia coli. Ann. Microbiol. 1980, 131, 31-37.
  • 11. Gyles C. L.: Escherichia coli enterotoxins, [w:] Gyles C. L. (wyd.), Escherichia coli in Domestic Animals and Humans. CAB International, Wallingford, Oxon, UK 1994, 171.
  • 12. Gyles C. L., Fairbrother J. M.: Escherichia coli, [w:] Gyles C. L., Prescott J. F., Songer J. G., Thoen C. O.: Pathogenesis of Bacterial Infections in Animals. Wiley-Blackwell, Ames, Iowa, USA 2010, 4th ed., 267-308.
  • 13. Joensuu J. J., Verdonck F., Ehrström A., Peltola M., Siljander-Rasi H., Nuutila A. M., Oksman-Caldentey K. M., Teeri T. H., Cox E., Goddeeris B. M., Niklander-Teeri V.: F4 (K88) fimbrial adhesion FaeG expressed in alfalfa reduces F4+ enterotoxigenic Escherichia coli excretion in weaned piglets. Vaccine 2006, 24, 2387-2394.
  • 14. Melkebeek V., Goddeeris B. M., Cox E.: ETEC vaccination in pigs. Vet. Immunol. Immunopathol. 2013, 152, 37-42.
  • 15. Nagy B., Fekete P. Z.: Enterotoxigenic Escherichia coli in veterinary medicine. Int. J. Med. Microbiol. 2005, 295, 443-454.
  • 16. Ngeleka M., Pritchard J., Appleyard G., Middleton D. M., Fairbrother J. M.: Isolation and association of Escherichia coli AIDA-I/STb, rather than EAST1 pathotype, with diarrhea in piglets and antibiotic sensitivity of isolates. J. Vet. Diagn. Invest. 2003, 15, 242-252.
  • 17. Rippinger P., Bertschinger H. U., Imberechts H., Nagy B., Sorg I., Stamm M., Wild P., Wittig W.: Designations F18ab and F18ac for the related fimbrial types F107, 2134P and 8813 of Escherichia coli isolated from porcine postweaning diarrhoea and from oedema disease. Vet. Microbiol. 1995, 45, 281-295.
  • 18. Ruan X., Liu M., Casey T. A., Zhang W.: A tripartite fusion, FaeG-FedFLT(192)A2:B, of enterotoxigenic Escherichia coli (ETEC) elicits antibodies that neutralize cholera toxin, inhibit adherence of K88 (F4) and F18 fimbriae, and protect pigs against K88ac/heat-labile toxin infection. Clinn. Vaccine Immunol. 2011, 18, 1593-1599.
  • 19. Schroyen M., Goddeeris B. M., Stinckens A., Verhelst R., Janssens S., Cox E., Georges M., Niewold T., Buys N.: The effect of enterotoxigenic Escherichia coli F4ab,ac on early-weaned piglets: A gene expression study. Vet. Immunol. Immunopathol. 2013, 152, 87-92.
  • 20. Tiels P., Verdonck F., Coddens A., Ameloot P., Goddeeris B. M., Cox E.: Monoclonal antibodies reveal a weak interaction between the F18 fimbrial adhesin FedF and the major subunit FedA. Vet. Microbiol. 2007, 119, 115-120.
  • 21. Tiels P., Verdonck F., Coddens A., Goddeeris B., Cox E.: The excretion of F18+ E. coli is reduced after oral immunisation of pigs with a FedF and F4 fimbriae conjugate. Vaccine 2008, 16, 2154-2163.
  • 22. Verdonck F., Tiels P., van Gog K., Goddeeris B. M., Lycke N., Clements J., Cox E.: Mucosal immunization of piglets with purified F18 fimbriae does not protect against F18+ Escherichia coli infection. Vet. Immunol. Immunopathol. 2007, 120, 69-79.
  • 23. Wilson R. A., Francis D. K.: Fimbriae and enterotoxins associated with Escherichia coli serogroups isolated from pigs with colibacillosis. Am. J. Vet. Res. 1986, 42, 213-217.

Typ dokumentu

Bibliografia

Identyfikatory

Identyfikator YADDA

bwmeta1.element.agro-43c3c62c-1b02-4f27-a30c-9e269146d415
JavaScript jest wyłączony w Twojej przeglądarce internetowej. Włącz go, a następnie odśwież stronę, aby móc w pełni z niej korzystać.